Relationship between home blood pressure and vascular function in patients receiving antihypertensive drug treatment.
arterial stiffness
endothelial function
hypertension
out-of-office blood pressure
vascular function
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
12
11
2018
accepted:
08
02
2019
revised:
18
01
2019
pubmed:
9
3
2019
medline:
23
9
2020
entrez:
9
3
2019
Statut:
ppublish
Résumé
Hypertension is associated with vascular failure, such as increased arterial stiffness, endothelial dysfunction, and vascular smooth muscle dysfunction. The purpose of this study was to investigate the relationship between out-of-office blood pressure and vascular function in patients receiving antihypertensive drugs. We assessed out-of-office blood pressure, including daytime and night-time blood pressure, by home blood pressure monitoring and performed vascular function tests, including brachial-ankle pulse wave velocity (baPWV), flow-mediated vasodilation (FMD), and nitroglycerine-induced vasodilation (NID), in 169 patients receiving antihypertensive drugs, of whom 86 (50.9%) had normotension, 23 (13.6%) had isolated nocturnal hypertension (night-time systolic blood pressure ≥120 mm Hg), 26 (15.4%) had isolated daytime hypertension (daytime systolic blood pressure ≥135 mm Hg), and 34 (20.1%) had sustained hypertension (daytime and nocturnal hypertension). baPWV was significantly higher in patients with sustained hypertension than in those without sustained hypertension (1585 ± 257 cm/s in normotension; 1687 ± 267 cm/s in isolated nocturnal hypertension; 1688 ± 313 cm/s in isolated daytime hypertension; and 1923 ± 399 cm/s in sustained hypertension; P < 0.001). baPWV above the cutoff value of 1858 cm/s, derived from receiver operating characteristic curve analysis to diagnose patients with sustained hypertension, was significantly associated with sustained hypertension after adjustment of other confounding factors (odds ratio, 5.01; 95% confidence interval, 1.94-13.41; P < 0.001). In contrast, there was no significant association of home blood pressure status with FMD or NID in these patients. In patients receiving antihypertensive drugs, baPWV was significantly associated with sustained hypertension, whereas FMD and NID were impaired regardless of the home blood pressure status.
Identifiants
pubmed: 30846869
doi: 10.1038/s41440-019-0240-8
pii: 10.1038/s41440-019-0240-8
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1175-1185Références
Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the united states: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.
doi: 10.1371/journal.pmed.1000058
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435–43.
doi: 10.1016/S0140-6736(15)00805-3
Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med. 2001;161:1183–92.
doi: 10.1001/archinte.161.9.1183
Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, et al. Coronary heart disease risk prediction in the atherosclerosis risk in communities (aric) study. J Clin Epidemiol. 2003;56:880–90.
doi: 10.1016/S0895-4356(03)00055-6
D’Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743–53.
doi: 10.1161/CIRCULATIONAHA.107.699579
Asayama K, Satoh M, Murakami Y, Ohkubo T, Nagasawa SY, Tsuji I. et al. Evidence for Cardiovascular Prevention from observational cohorts in Japan Research Group Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population: participant-level meta-analysis. Hypertension. 2014;63:1189–97.
doi: 10.1161/HYPERTENSIONAHA.113.03206
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. Japanese Society of Hypertension Committee for Guidelines for the management of hypertyension(JSH 2014). Hypertens Res. 2014;37:253–390.
doi: 10.1038/hr.2013.80
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 acc/aha/aapa/abc/acpm/ags/apha/ash/aspc/nma/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–e115.
pubmed: 29133356
Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in ohasama, Japan. J Hypertens. 1998;16:971–5.
doi: 10.1097/00004872-199816070-00010
Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. New Engl J Med. 2018;378:1509–20.
doi: 10.1056/NEJMoa1712231
Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K. et al.International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes investigators Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.
doi: 10.1016/S0140-6736(07)61538-4
Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cifkova R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the european society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (artery) society. Atherosclerosis. 2015;241:507–32.
doi: 10.1016/j.atherosclerosis.2015.05.007
Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman. A Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc. 2015;4:e002270.
Kajikawa M, Maruhashi T, Hida E, Iwamoto Y, Matsumoto T, Iwamoto A, et al. Combination of flow-mediated vasodilation and nitroglycerine-induced vasodilation is more effective for prediction of cardiovascular events. Hypertension. 2016;67:1045–52.
doi: 10.1161/HYPERTENSIONAHA.115.06839
Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y. et al.Collaborative Group for J-BAVEL Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension. 2017;69:1045–52.
doi: 10.1161/HYPERTENSIONAHA.117.09097
Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a chinese population study. Hypertension. 2007;50:333–9.
doi: 10.1161/HYPERTENSIONAHA.107.087767
Alioglu E, Turk UO, Bicak F, Tengiz I, Atila D, Barisik V, et al. Vascular endothelial functions, carotid intima-media thickness, and soluble cd40 ligand levels in dipper and nondipper essential hypertensive patients. Clin Res Cardiol. 2008;97:457–62.
doi: 10.1007/s00392-008-0654-9
Wijkman M, Lanne T, Engvall J, Lindstrom T, Ostgren CJ, Nystrom FH. Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes. Diabetologia. 2009;52:1258–64.
doi: 10.1007/s00125-009-1369-9
Kario K, Hoshide S, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S. et al.J-HOP study group Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan morning surge home blood pressure (J-HOP) study. J Clin Hypertens. 2015;17:340–8.
doi: 10.1111/jch.12500
Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Human Hypertens. 2005;19:401–6.
doi: 10.1038/sj.jhh.1001838
Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–7.
doi: 10.1097/HJH.0b013e32832e94e7
Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60:556–62.
doi: 10.1161/HYPERTENSIONAHA.112.194779
Yamashina A, Tomiyama H, Arai T, Koji Y, Yambe M, Motobe H, et al. Nomogram of the relation of brachial-ankle pulse wave velocity with blood pressure. Hypertens Res. 2003;26:801–6.
doi: 10.1291/hypres.26.801
Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension. 2002;39:1083–7.
doi: 10.1161/01.HYP.0000019132.41066.95
Tomiyama H, Komatsu S, Shiina K, Matsumoto C, Kimura K, Fujii M, et al. Effect of wave reflection and arterial stiffness on the risk of development of hypertension in japanese men. J Am Heart Assoc. 2018;7:e008175.
Hosohata K, Kikuya M, Ohkubo T, Metoki H, Asayama K, Inoue R, et al. Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home. Hypertens Res: Off J Jpn Soc Hypertens. 2007;30:707–12.
doi: 10.1291/hypres.30.707
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–5.
doi: 10.1016/0140-6736(92)93147-F
Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.
doi: 10.1253/circj.CJ-08-1102
Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998;32:123–7.
doi: 10.1016/S0735-1097(98)00206-X
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol. 2013;33:1401–8.
doi: 10.1161/ATVBAHA.112.300934
Gokce N, Holbrook M, Duffy SJ, Demissie S, Cupples LA, Biegelsen E, et al. Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension. 2001;38:1349–54.
doi: 10.1161/hy1201.096575
Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779–82.
doi: 10.1016/S0002-8703(96)90311-7
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Endothelial function is impaired in patients receiving antihypertensive drug treatment regardless of blood pressure level: FMD-J Study (flow-mediated dilation Japan). Hypertension. 2017;70:790–7.
doi: 10.1161/HYPERTENSIONAHA.117.09612
Tomiyama H, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, et al. Reliability of measurement of endothelial function across multiple institutions and establishment of reference values in Japanese. Atherosclerosis. 2015;242:433–42.
doi: 10.1016/j.atherosclerosis.2015.08.001